Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | CTSV | O60911 | 1/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | ADK | P55263 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.35 |
| ▸ | PDE9A | O76083 | 1/20 | 0.35 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | TNKS | O95271 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14181758 | 0.88 | ACHE (0.45) | ACHERAB9ACTSVCTSLHPGD | |
| SCHEMBL1262728 | 0.88 | ACHE (0.47) | ACHEGSK3BADKPTGS2PDE9A | |
| SCHEMBL14160409 | 0.86 | ACHE (0.47) | ACHERAB9AHPGDMEN1KMT2A | |
| SCHEMBL14211423 | 0.86 | ALDH1A1 (0.36) | ACHEHPGDMEN1KMT2AL3MBTL1 | |
| SCHEMBL10063900 | 0.86 | ACHE (0.44) | ACHEGSK3BADKMEN1KMT2A | |
| SCHEMBL10063905 | 0.85 | ACHE (0.46) | ACHERAB9AHPGDMEN1KMT2A | |
| SCHEMBL14181736 | 0.85 | ACHE (0.42) | ACHERAB9ACTSVCTSLHPGD | |
| SCHEMBL12619868 | 0.84 | ACHE (0.45) | ACHEGSK3BADKMEN1KMT2A | |
| SCHEMBL11954097 | 0.84 | ACHE (0.45) | ACHEGSK3BADKMEN1KMT2A | |
| SCHEMBL14942362 | 0.84 | ALDH1A1 (0.42) | ACHERAB9AHPGDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120309974-A1 | Bianthracene compounds substituted by aromatic ring and their uses for luminescence materials | BEIJING AGLAIA TECHNOLOGY DEVELOPMENT CO., LTD (CN) | 2012-12-06 | — | — | US | disclosed |
| US-20120309974-A1 | Bianthracene compounds substituted by aromatic ring and their uses for luminescence materials | BEIJING AGLAIA TECHNOLOGY DEVELOPMENT CO., LTD (CN) | 2012-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309974-A1 | Bianthracene compounds substituted by aromatic ring and their uses for luminescence materials | TYR, GALNT1, GALNT2 | ACHE 1323/4885RAB9A 460/4885CTSV 2456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.